BioLineRx Ltd.

Regulatory Filings • Jul 10, 2013

_________ false

C007������� �� ��� ��"�2PublicBIOLINE RX LTD9253Corporation no: 513398750Stock Exchange/Market: NASDAQ-SC2271428����� 19 , ������� 91450 , ,Tel: 02-5489100 , 02-5489116 Fax: 02-5489101E.mail address: info@BioLineRx.comReported via MAGNA: 10/07/2013              Time of broadcast: 13:50 13:44:12

Reference: 2013-02-089427

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 15/08/2013 at 11:00 the corporation will hold it's annual general meetingat 19 Hartum Street, Har Hotzvim, JerusalemNumber of the security that entitles its holder to vote at the meeting: 1101518The Number - as given by the Tel Aviv Stock Exchange

According to section 182 B of the Companies law, 5759-1999, only shareholders of record at the close of business 15/07/2013 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report 6-K_AGM2013_1_isa.pdf

Attached hereto is the proxy statement 6-K_AGM2013_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 26/06/2013
- - -
Name of the Signatory: : Kotler Norman Harold , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: .
Hartum Telephone: 02-5489100 , Facsimile: 02-5489101 , E-mail: normank@biolinerx.com 1